These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 17342743)
1. Effects of dietary saw palmetto on the prostate of transgenic adenocarcinoma of the mouse prostate model (TRAMP). Wadsworth TL; Worstell TR; Greenberg NM; Roselli CE Prostate; 2007 May; 67(6):661-73. PubMed ID: 17342743 [TBL] [Abstract][Full Text] [Related]
2. Effect of permixon on human prostate cell growth: lack of apoptotic action. Hill B; Kyprianou N Prostate; 2004 Sep; 61(1):73-80. PubMed ID: 15287095 [TBL] [Abstract][Full Text] [Related]
3. Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase II. Pais P Adv Ther; 2010 Aug; 27(8):555-63. PubMed ID: 20623347 [TBL] [Abstract][Full Text] [Related]
4. A preliminary investigation of the enzymatic inhibition of 5alpha-reduction and growth of prostatic carcinoma cell line LNCap-FGC by natural astaxanthin and Saw Palmetto lipid extract in vitro. Anderson ML J Herb Pharmacother; 2005; 5(1):17-26. PubMed ID: 16093232 [TBL] [Abstract][Full Text] [Related]
5. Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression. Habib FK; Ross M; Ho CK; Lyons V; Chapman K Int J Cancer; 2005 Mar; 114(2):190-4. PubMed ID: 15543614 [TBL] [Abstract][Full Text] [Related]
6. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens. Marks LS; Hess DL; Dorey FJ; Luz Macairan M; Cruz Santos PB; Tyler VE Urology; 2001 May; 57(5):999-1005. PubMed ID: 11337315 [TBL] [Abstract][Full Text] [Related]
7. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line. Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094 [TBL] [Abstract][Full Text] [Related]
8. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Mentor-Marcel R; Lamartiniere CA; Eltoum IE; Greenberg NM; Elgavish A Cancer Res; 2001 Sep; 61(18):6777-82. PubMed ID: 11559550 [TBL] [Abstract][Full Text] [Related]
9. Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells. Wadsworth TL; Carroll JM; Mallinson RA; Roberts CT; Roselli CE Endocrinology; 2004 Jul; 145(7):3205-14. PubMed ID: 15033918 [TBL] [Abstract][Full Text] [Related]
10. Saw Palmetto induces growth arrest and apoptosis of androgen-dependent prostate cancer LNCaP cells via inactivation of STAT 3 and androgen receptor signaling. Yang Y; Ikezoe T; Zheng Z; Taguchi H; Koeffler HP; Zhu WG Int J Oncol; 2007 Sep; 31(3):593-600. PubMed ID: 17671686 [TBL] [Abstract][Full Text] [Related]
11. Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract. Kumar AP; Bhaskaran S; Ganapathy M; Crosby K; Davis MD; Kochunov P; Schoolfield J; Yeh IT; Troyer DA; Ghosh R Clin Cancer Res; 2007 May; 13(9):2784-94. PubMed ID: 17473212 [TBL] [Abstract][Full Text] [Related]
12. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model. Pflug BR; Pecher SM; Brink AW; Nelson JB; Foster BA Prostate; 2003 Nov; 57(3):245-54. PubMed ID: 14518031 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the DHT-induced PSA secretion by Verbascum xanthophoeniceum and Serenoa repens extracts in human LNCaP prostate epithelial cells. Marcoccia D; Georgiev MI; Alipieva KI; Lorenzetti S J Ethnopharmacol; 2014 Aug; 155(1):616-25. PubMed ID: 24928827 [TBL] [Abstract][Full Text] [Related]
14. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model. Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of Serenoa repens on the kinetic of pig prostatic microsomal 5alpha-reductase activity. Palin MF; Faguy M; LeHoux JG; Pelletier G Endocrine; 1998 Aug; 9(1):65-9. PubMed ID: 9798732 [TBL] [Abstract][Full Text] [Related]
16. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response. Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory properties of Lipidosterolic extract of Serenoa repens (Permixon®) in a mouse model of prostate hyperplasia. Bernichtein S; Pigat N; Camparo P; Latil A; Viltard M; Friedlander G; Goffin V Prostate; 2015 May; 75(7):706-22. PubMed ID: 25683150 [TBL] [Abstract][Full Text] [Related]
18. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model. Raghow S; Kuliyev E; Steakley M; Greenberg N; Steiner MS Cancer Res; 2000 Aug; 60(15):4093-7. PubMed ID: 10945615 [TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H Cancer Res; 2000 Sep; 60(18):5125-33. PubMed ID: 11016639 [TBL] [Abstract][Full Text] [Related]
20. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Wechter WJ; Leipold DD; Murray ED; Quiggle D; McCracken JD; Barrios RS; Greenberg NM Cancer Res; 2000 Apr; 60(8):2203-8. PubMed ID: 10786685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]